Biosensics

Cambridge, United States Founded: 2011 • Age: 15 yrs
Wearable sensors for posture, gait analysis, ECG for elders.

About Biosensics

Biosensics is a company based in Cambridge (United States) founded in 2011. Biosensics has raised $3 million across 33 funding rounds from investors including NIH and HHS. The company has 14 employees. Biosensics offers products and services including BalanSens, LEGSys, PAMSys, BioDigit Speech, and BioDigit Video. Biosensics operates in a competitive market with competitors including Endotronix, Edwards Lifesciences, CoachCare, SafelyYou and BioIntelliSense, among others.

  • Headquarter Cambridge, United States
  • Employees 14
  • Sectors
    Healthcare
    Technology
  • Website biosensics.com
  • Social LinkedIn X
  • Legal Name Biosensics Llc
Key Metrics
  • Total Equity Funding
    $3M (USD)

    in 33 rounds

  • Latest Funding Round
    $1.97M (USD), Grant

    Sep 2023

  • Investors
    NIH

    & 1 more

  • Employee Count
    14

Products & Services of Biosensics

Biosensics offers a comprehensive portfolio of products and services, including BalanSens, LEGSys, PAMSys, BioDigit Speech, and BioDigit Video.

BalanSens
Wearable Devices

Wearable for balance assessment in patient monitoring.

LEGSys
Wearable Devices

System for gait analysis in clinical trials.

PAMSys
Wearable Devices

Device for activity monitoring and fall detection.

BioDigit Speech
Digital Health

Platform for speech analysis in health assessment.

BioDigit Video
Digital Health

Tool for video-based biomarker data collection.

Funding Insights of Biosensics

Biosensics has successfully raised a total of $3M across 33 strategic funding rounds. The most recent funding activity was a Grant round of $1.97 million completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $3M
  • Total Rounds 33
  • Last Round Grant β€” $1.97M
  • First Round $100,000

    (Apr 2009)

  • Investors Count 2

Latest 10 of 33 funding rounds of Biosensics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2023$1.97MGrant––
Jul 2023$500,011Grant––
Jul 2023$3MSeed––
–
Jun 2023$1.88MGrant––
Apr 2023$275,000Grant––
Jan 2023$1.51MGrant––
Sep 2022$2.55MGrant––
Sep 2020$256,000Grant––
Aug 2020$3.17MGrant––
Jul 2020$348,832Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in Biosensics

Biosensics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NIH and HHS.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Public health and human services are overseen by HHS.
1953hhs.gov-
Drug discovery services are provided to the biopharma sector.
1887nih.govUnited States
Premium access

Investor details for Biosensics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Biosensics

8 people are tracked at Biosensics (4 in leadership, 4 in team); the tracked headcount is 14.

NameRoleGroup
Ashkan Vaziri
CEOLeadership
Kevin Borth
Director of Quality and ComplianceLeadership
Gregory Barchard
Vice President Of EngineeringLeadership
Ana Enriquez
Director Of Clinical OperationsLeadership
João Carlos Barbosa
Test & Manufacturing EngineerTeam
Karl Obermiller
Senior Software EngineerTeam
James Lim
Clinical Operations ManagerTeam
Office Manager
Office ManagerTeam
Premium access

Complete people profiles for Biosensics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Biosensics

3 dated milestones of Biosensics across 14 years, from founding to its latest funding, stage changes and deals.

  1. Funding First funding round of $100K.
  2. Founded Biosensics is founded.
  3. Funding Latest funding round, Grant, of $2.0M.

Competitors of Biosensics

Biosensics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Endotronix, Edwards Lifesciences, CoachCare, SafelyYou and BioIntelliSense, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
endotronix.com2007East Peoria, United States$154.77M104
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring.
edwards.com1958Irvine, United States–19,800
Medical devices for structural heart disease are developed and provided.
coachcare.com2013New York, United States$60.2M–
Remote monitoring platform for tracking patient activity
safely-you.com2014San Francisco, United States$102.5M85
AI-based fall detection and prevention technology is provided for clinics.
biointellisense.com2018Redwood, United States$82M26
Vital signs are monitored via a single-use patch and platform.
oxehealth.com2012Leeds, United Kingdom$7.14M95
Contactless patient monitoring is provided for mental health facilities.
openwater.health2016San Francisco, United States$54M–
Provider of imaging technologies for medical diagnosis and treatments
higi.com2012Chicago, United States$95.23M53
Gamified app for personal health management
somatix.com2015New York, United States$21.24M–
AI-based remote health monitoring tools are provided for patient care.
testcard.com2016London, United Kingdom$20.22M39
TestCard is recognized as a digital diagnostics platform provider.
Premium access

Detailed competitors of Biosensics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Biosensics

Websites that share an audience with Biosensics (biosensics.com).

Similar websites

Websites whose visitors overlap most with Biosensics. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
biovotion.com
100%
––View details
vandrico.com
94%
––View details
imedicalapps.com
84%
–#1,659,875View details
tcaholdings.com
tcaholdings.com
55%
–––

Latest news on Biosensics

Premium access

Complete news archive for Biosensics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Biosensics

10 companies that operate in the same segment as Biosensics (Aging & Geriatric Care), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
AI-based fall detection and prevention technology is provided for clinics.
2014San Francisco, California, United StatesUSD 102.5 M–85
AI-based social robots are provided as companions for the elderly.
2015Tel Aviv, IsraelUSD 76 M––
Smart lamp for elderly fall detection is provided.
2018Antwerp, BelgiumUSD 51.23 MUSD 783.91 K12
Genetically targeted therapies for age-related diseases are developed.
2014Seattle, Washington, United StatesUSD 27.51 M––
Assistive aids for elderly are provided via non-wearable sensors.
2017New York, New York, United StatesUSD 12.11 M––
Senior activities are monitored via AI wearables to detect anomalies.
2013Fort Lauderdale, Florida, United StatesUSD 54.14 M––
Technology is developed by Sage for senior living communities.
2019New York, New York, United StatesUSD 59 M––
Immunotherapies for cancer are developed using viral vectors targeting retroviruses.
2018Copenhagen, DenmarkUSD 18.17 M–13
Provider of medical alert system for older adults
2005Philadelphia, Pennsylvania, United States–––
Gene-editing platform and anti-aging therapy for dogs are developed.
2017San Diego, California, United StatesUSD 34.05 M–39
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Biosensics

Biosensics was founded in 2011.

Biosensics is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.

Ashkan Vaziri is the current CEO of Biosensics.

Biosensics is a funded company, having raised a total of $3M across 33 funding rounds to date. The company's 1st funding round was a Grant of $348.83K, raised on Apr 2009.

Biosensics has 14 employees.

Founded in 2011 in Cambridge, United States, BioSensics operates in the health technology sector with a focus on elderly care. Wearable sensors are created to support posture analysis, gait assessment, transition monitoring, and fall detection. The PAMSys system is designed as an integrated ECG tool for remote co-monitoring of these functions using a single device. Products are directed toward applications in elder health management.

Biosensics's top competitors include Endotronix, SafelyYou and TestCard.

Biosensics offers BalanSens, LEGSys, PAMSys, BioDigit Speech, and BioDigit Video.

Biosensics has 2 investors. Key investors include NIH, and HHS.

Biosensics operates through Biosensics Llc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available